Newborn whole genome sequencing complements rather than competes with population health

We welcome Sheldon and Wright’s emphasis on social determinants of health rather than screening,1 but universal newborn whole genome sequencing (WGS) should be seen as an evolution of the heel prick programme, rather than a costly detour into genomics for its own sake. Biochemical screening already tests nine conditions; adding WGS widens that net to >200 treatable disorders and creates a …